Also known as: AM833
Cagrilintide is a long-acting amylin agonist, categorized under fat loss and metabolic peptides. This peptide is designed to mimic the effects of the hormone amylin, which is co-secreted with insulin by pancreatic beta cells. Cagrilintide plays a significant role in regulating glucose metabolism and appetite control, making it a subject of interest in metabolic research.
Cagrilintide is primarily studied for its potential in weight management and metabolic health. By enhancing the physiological functions of amylin, it aims to assist in reducing body fat and improving overall metabolic profiles in various populations.
Cagrilintide operates by binding to amylin receptors in the brain and peripheral tissues, leading to several physiological responses.
Upon activation of these receptors, Cagrilintide influences appetite regulation and glucose homeostasis. It slows gastric emptying, which contributes to increased satiety and reduced food intake. Additionally, it helps modulate insulin secretion, thereby improving glucose control in the body.
Cagrilintide is a promising peptide in the realm of metabolic health, particularly for its role as a long-acting amylin agonist. Its mechanisms of action suggest potential benefits in weight management and glucose regulation, making it a valuable subject for ongoing research in metabolic disorders.
Last updated: Feb 25, 2026